{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/hypertension-not-diabetic/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"a4dad1ea-40da-5ed2-85b0-8b5ea72bc196","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field 19d3a65f-f4e0-4d37-996f-0282971a1d9e --><h2>Update</h2><!-- end field 19d3a65f-f4e0-4d37-996f-0282971a1d9e -->","summary":null,"htmlStringContent":"<!-- begin item 909880b6-65d5-4419-99f6-e46b85a9531e --><!-- end item 909880b6-65d5-4419-99f6-e46b85a9531e -->","topic":{"id":"c1c1e500-a3f1-5baa-8d5f-890b15f767cc","topicId":"8de59d12-a526-4ab9-8496-1fcb59d838ff","topicName":"Hypertension - not diabetic","slug":"hypertension-not-diabetic","lastRevised":"Last revised in September 2020","chapters":[{"id":"2f82c42a-b82b-549e-9b10-218d9f782bf8","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"a5985652-a8b7-51c0-b2d2-6836d4507f90","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"95f1a40b-c079-5c37-af45-5e0806a2bcae","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"4f16b189-bff9-5dfe-82a9-fdd4cd035ab0","slug":"changes","fullItemName":"Changes"},{"id":"a4dad1ea-40da-5ed2-85b0-8b5ea72bc196","slug":"update","fullItemName":"Update"}]},{"id":"b0107535-58ec-5e22-ac3b-22ae41ade390","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f76e08e3-badc-526a-835f-8f549cc3f784","slug":"goals","fullItemName":"Goals"},{"id":"928c1147-d56a-5b8a-94f7-87ddad3ef460","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"aae28613-e6a5-5ba1-b4fa-e5032a9918ac","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7bf8c570-8757-5ae3-802f-5cba9e5ceb86","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"3ace22a3-d042-5a6a-9d63-3527cf484a0a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"c1a38cc6-4765-5c16-9f08-592cfc9851a3","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"066993d8-fd33-59fb-877b-6e8418b515d1","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"15ade196-5491-5552-9df6-a17d4c9c69d7","slug":"definition","fullItemName":"Definition"},{"id":"4528059a-b33b-51d3-8c65-983b4c165a3a","slug":"prevalence","fullItemName":"Prevalence"},{"id":"3e698434-11c9-553c-96a6-a249bf121cbb","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"0bec257d-f02e-5030-a430-8accc5245e7f","slug":"complications-prognosis","fullItemName":"Complications and prognosis"}]},{"id":"e56e7d7e-9afc-5c38-a77a-8f2b80461457","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"7dcedb3e-c4f4-55ff-9910-03ee5ed41bb4","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"a6466983-7adb-5a4f-8864-f3ecc06b447a","slug":"investigations","fullItemName":"Investigations"}]},{"id":"33227758-4699-5e51-be33-b22dca2eb654","fullItemName":"Management","slug":"management","subChapters":[{"id":"d6332f04-a86e-56ef-9e25-d77083a8371c","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"0cfca07e-cadc-55c1-81ed-fcdb236f4835","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"92190a49-9e8d-5fae-93b2-cf6243cfc01b","slug":"angiotensin-converting-enzyme-inhibitors","fullItemName":"Angiotensin-converting enzyme inhibitors"},{"id":"5ee249d0-bc66-59a5-8138-2449798ff2eb","slug":"angiotensin-ii-receptor-blockers","fullItemName":"Angiotensin-II receptor blockers"},{"id":"115bec24-ba4e-5f2a-80dc-dee6e948a288","slug":"thiazide-type-diuretics","fullItemName":"Thiazide-type diuretics"},{"id":"2ae4ccdd-d119-5a5a-9c89-d6493f2552f2","slug":"calcium-channel-blockers","fullItemName":"Calcium-channel blockers"},{"id":"44681f3b-7958-5edd-a944-eb440f1df250","slug":"spironolactone","fullItemName":"Spironolactone"},{"id":"cb9a67f7-3588-5c68-b3d5-6c63d50ad0b8","slug":"beta-blockers","fullItemName":"Beta-blockers"},{"id":"5740c79c-d5a7-5547-ab38-db87df2b9121","slug":"alpha-blockers","fullItemName":"Alpha-blockers"},{"id":"f3424e7c-5446-59b0-b50e-0724587bb306","slug":"covid-19","fullItemName":"COVID-19"}]},{"id":"3b3191c9-bff5-563f-b5c0-09e8a0d22441","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"7d204db0-8ff2-556e-97b4-89516ac7819b","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"0f686cda-dcaf-5f12-b5d6-871aefae47fe","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"dfcaec55-3c23-5a3f-9c08-f151a3120dc2","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"804073cd-b49f-5e4a-bf85-90faf125ad0e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"613e4289-93db-5311-aa87-b5a7a6e82dd1","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6e42a873-c39f-5405-bf4f-efdd81187ea2","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"2b87bc1c-2b4a-556b-b320-6b4f18bcf85d","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"95f1a40b-c079-5c37-af45-5e0806a2bcae","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"0ce507bf-e441-55f1-8c8b-14bdedc049ac","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field 4913ebbf-57f9-4005-a1c8-481f371f741b --><h3>New evidence</h3><!-- end field 4913ebbf-57f9-4005-a1c8-481f371f741b -->","summary":null,"htmlStringContent":"<!-- begin item b101ac32-2afa-4930-aea9-beaf7e0f636c --><!-- begin field f9a58b37-f827-41ee-b8d9-f93287198d1f --><h3>Evidence-based guidelines</h3><!-- end field f9a58b37-f827-41ee-b8d9-f93287198d1f --><!-- begin field b4ce9adc-30c1-47fc-b714-3c00e8fa65b1 --><ul><li>SIGN (2017) <em>Cardiac rehabilitation</em>. Scottish Intercollegiate Guidelines Network. <a href=\"https://www.sign.ac.uk/\" data-hyperlink-id=\"c4cf2e41-c426-476a-b8cf-a8f7014e8218\">www.sign.co.uk</a> [<a href=\"http://www.sign.ac.uk/sign-150-cardiac-rehabilitation.html\" data-hyperlink-id=\"6b2f5310-da15-4111-8ffc-a8f7014e8227\">Free Full-text</a>]</li><li>SIGN (2017) <em>Risk estimation and the prevention of cardiovascular disease</em>. Scottish Intercollegiate Guidelines Network. <a href=\"https://www.sign.ac.uk/\" data-hyperlink-id=\"c510351c-ba93-4cc9-9e50-a8f7014e8239\">www.sign.co.uk</a> [<a href=\"http://www.sign.ac.uk/sign-149-risk-estimation-and-the-prevention-of-cardiovascular-disease.html\" data-hyperlink-id=\"17180b21-a4b6-45d8-be3d-a8f7014e823f\">Free Full-text</a>]</li><li>Carey, R.M., and Whelton, P.K. (2018) Prevention, detection, evaluation, and management of high blood pressure in adults: synopsis of the 2017 American college of cardiology/American heart association hypertension guideline. American College of Physicians. <a href=\"https://www.acponline.org/\" data-hyperlink-id=\"11e00bbb-02f7-4f6e-992d-a8f7014e82cf\">www.acponline.org </a> [<a href=\"http://annals.org/aim/fullarticle/2670318/prevention-detection-evaluation-management-high-blood-pressure-adults-synopsis-2017\" data-hyperlink-id=\"f3527bce-e43e-4e26-b837-a8f7014e838a\">Free Full-Text</a>]</li><li>Ioannidis, J. P. (2018) Diagnosis and treatment of hypertension in the 2017 ACC/AHA guidelines and in the real world.<em> JAMA</em><strong> 319</strong>(2), 115-116. [<a href=\"http://jamanetwork.com/journals/jama/article-abstract/2666624?redirect=true\" data-hyperlink-id=\"860df028-72e9-4b71-9abe-a8f7014e848c\">Free full-text</a>]</li><li>Sheppard, J.P., Martin, U., and McManus, R.J. (2017) Diagnosis and management of resistant hypertension. <em>Heart</em> <strong>epub ahead of print</strong>.</li><li>Whelton, P.K., Carey, R.M., Jessup, M., et al. (2017) Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.<em> Hypertension</em> <strong>epub ahead of print</strong>.</li><li>Ng, F. L., Lobo, M. D. (2018)<em> Investigation and management of adult hypertension</em>. BMJ <a href=\"http://journals.bmj.com/\" data-hyperlink-id=\"210a9895-d0bf-4e1a-ae45-a8f7014e8849\">www.bmj.com</a> [<a href=\"http://heart.bmj.com/content/early/2018/03/02/heartjnl-2017-311443\" data-hyperlink-id=\"36c27cb9-16f3-4bb6-9baa-a8f7014e8852\">Free Full-Text</a>]</li><li>BHF (2018) <em>Blood pressure: how can we do better? </em>British Heart Foundation. <a href=\"https://www.bhf.org.uk/\" data-hyperlink-id=\"e19b40a3-fc32-4214-a24f-a8f7014e885b\">www.bhf.org.uk</a> [<a href=\"https://www.bhf.org.uk/healthcare-professionals/commissioning-and-services/service-innovation/bp-how-can-we-do-better#resources\" data-hyperlink-id=\"dcd3d861-b2b0-4748-8804-a8f7014e888f\">Free Full-text</a>]</li><li>ESC (2018) <em>What is a normal blood pressure? </em>European Society of Cardiology. <a href=\"https://academic.oup.com/eurheartj\" data-hyperlink-id=\"ae5ec99a-b5fa-4dab-a0d3-a90000a0e305\">www.academic.oup.com</a> [<a href=\"https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehy330/5035212#117696688\" data-hyperlink-id=\"a91ca962-1a04-4a2b-8736-a90000a0e436\">Free Full-text</a>]</li><li>NIHR (2018) Self-monitoring improves control of high blood pressure compared with GP monitoring alone. National Institute for Health Research. [<a href=\"https://discover.dc.nihr.ac.uk/content/signal-000615/control-of-high-blood-pressure-can-be-improved-by-self-monitoring-compared-with-gp-monitoring-alone\" data-hyperlink-id=\"8f68130f-d0bc-4b2b-8283-a91f00dec5b8\">Free Full-text</a>]</li><li>Williams, B., et al. (2018)<em> 2018 ESC/ESH Guidelines for the management of arterial hypertension. </em>European Heart Journal. [<a href=\"https://academic.oup.com/eurheartj/article/39/33/3021/5079119#120444720\" data-hyperlink-id=\"28dd6f5e-a055-41ca-a47c-a96700a92cd3\">Free Full-text</a>]</li></ul><!-- end field b4ce9adc-30c1-47fc-b714-3c00e8fa65b1 --><!-- begin field d25d791b-be00-4f80-9a1a-74f9c097b905 --><h3>HTAs (Health Technology Assessments)</h3><!-- end field d25d791b-be00-4f80-9a1a-74f9c097b905 --><!-- begin field 2bbb433b-e5f2-4dd1-a1b2-ead40ca55f6e --><p>No new HTAs since 1 June 2017.</p><!-- end field 2bbb433b-e5f2-4dd1-a1b2-ead40ca55f6e --><!-- begin field fb4721c0-42f7-435b-9b39-8420a5e95fa4 --><h3>Economic Appraisals</h3><!-- end field fb4721c0-42f7-435b-9b39-8420a5e95fa4 --><!-- begin field d3087a73-b5d7-4ab5-ad22-76f1f452079d --><p>No new economic appraisals relevant to England since 1 June 2017.</p><!-- end field d3087a73-b5d7-4ab5-ad22-76f1f452079d --><!-- begin field 244a783b-4ffe-4c00-b5d9-ceb494a5d7e6 --><h3>Systematic reviews and meta-analyses</h3><!-- end field 244a783b-4ffe-4c00-b5d9-ceb494a5d7e6 --><!-- begin field 6db34484-f75b-4e06-a91b-5f69f724586d --><ul><li>Hwang, A. Y., Dave, C. V., and Smith, S. S. (2018) <em>Use of Prescription Medications That Potentially Interfere With Blood Pressure Control in New-Onset Hypertension and Treatment-Resistant Hypertension. </em>American Journal of Hypertension. <a href=\"https://academic.oup.com/journals\" data-hyperlink-id=\"13337306-2130-4f81-b7b5-a95700e437c9\">www.academic.oup.com</a> [<a href=\"https://academic.oup.com/ajh/advance-article-abstract/doi/10.1093/ajh/hpy118/5059669?redirectedFrom=fulltext\" data-hyperlink-id=\"d4d48d2f-189d-4729-a50c-a95700e438f4\">Free Full-text</a>]</li><li>Musini, V., Tejani, A., Bassett, K., et al. (2019) <em>Pharmacotherapy for hypertension in adults 60 years or older. </em>Cochrane Library. <a href=\"https://www.cochranelibrary.com/\" data-hyperlink-id=\"4e4d1e40-1702-4917-aa22-aaaf00b17a4f\">www.cochranelibrary.com</a> [<a href=\"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000028.pub3/full\" data-hyperlink-id=\"c6e9f0ea-e803-4e54-97b9-aaaf00b17aa0\">Free Full-text</a>]</li><li>Hernandez, A., Emonds, E., Chen, B., et al. (2019) <em>Effect of low-sodium salt substitutes on blood pressure, detected hypertension, stroke and mortality. </em>British Medical Journal. <a href=\"https://journals.bmj.com/\" data-hyperlink-id=\"37528f20-3ccd-4763-b6d0-a9e4009d0698\">www.journals.bmj.com</a> [<a href=\"https://heart.bmj.com/content/early/2019/01/18/heartjnl-2018-314036\" data-hyperlink-id=\"427bd7ef-1629-440e-bf73-a9e4009d06af\">Free Full-text</a>]</li><li>Arguedas, J.A., Leiva, V., Wright, J.M. (2020) <em>Blood pressure targets in adults with hypertension</em>. Cochrane Library. <a href=\"https://www.cochranelibrary.com/\" data-hyperlink-id=\"4eae47ea-b531-43df-ae76-ac9500b7d950\">www.cochranelibrary.com</a> [<a href=\"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004349.pub3/full\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"ef41ef7d-b215-4bb4-82f5-ac9500b7d950\">Free Full-text</a>]</li></ul><!-- end field 6db34484-f75b-4e06-a91b-5f69f724586d --><!-- begin field 3fbf0331-8c3f-4534-a563-dcb8dfdc8587 --><h3>Primary evidence</h3><!-- end field 3fbf0331-8c3f-4534-a563-dcb8dfdc8587 --><!-- begin field 2d1e7118-24cb-4409-8174-7553be74c25b --><ul><li>Wang, Z., Wang, X., Shen, Y., et al. (2020) <em>Effect of a workplace-based multicomponent intervention on hypertension control.</em> JAMA Cardiology. <a href=\"https://jamanetwork.com/\" data-hyperlink-id=\"de53ba8c-5811-48ab-95a5-ab7600dffeae\">www.jamanetwork.com</a> [<a href=\"https://jamanetwork.com/journals/jamacardiology/article-abstract/2761580\" data-hyperlink-id=\"ef10569d-d434-4d23-863d-ab7600dfff80\">Abstract</a>]</li><li>Sinnott, S-J., Douglas, I.J., Smeeth, L., et al. (2020) <em>First line drug treatment for hypertension and reductions in blood pressure according to age and ethnicity: cohort study in UK primary care.</em> BMJ. <a href=\"https://www.bmj.com/\" data-hyperlink-id=\"63264cd9-1753-43bd-83ae-ac7900c3c49d\">www.bmj.com</a> [<a href=\"https://www.bmj.com/content/371/bmj.m4080\" data-hyperlink-id=\"b828bc01-c7fd-46d9-861a-ac7900c3c4b2\">Free Full-text</a>]</li><li>Harrison, P.J., Colbourne, L., Luciano, S. (2021) <em>Incidence of neurodegenerative and cerebrovascular diseases associated with antihypertensive drug classes. </em>British Journal of Psychiatry. <a href=\"http://www.cambridge.org/\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"841baf8a-29c2-4897-829c-acaa00ff0356\">www.cambridge.org</a> [<a href=\"https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/abs/incidence-of-neurodegenerative-and-cerebrovascular-diseases-associated-with-antihypertensive-drug-classes/F9BDF21B6305CAE266B9DC8377E924D6\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"6b72e864-062e-417d-a20c-acaa00ff0356\">Abstract</a>]</li></ul><!-- end field 2d1e7118-24cb-4409-8174-7553be74c25b --><!-- end item b101ac32-2afa-4930-aea9-beaf7e0f636c -->","subChapters":[]},{"id":"ba706ba4-f9eb-5c41-8ce1-e7eda812921b","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field c950cf62-4fd0-4ea3-9775-3504d514856b --><h3>New policies</h3><!-- end field c950cf62-4fd0-4ea3-9775-3504d514856b -->","summary":null,"htmlStringContent":"<!-- begin item aa3e3c90-87cc-4a94-bd38-a29059be07f1 --><!-- begin field 19749c71-64ee-4ba4-9448-00ca2f82c7f2 --><p>No new national policies or guidelines since 1 June 2017.</p><!-- end field 19749c71-64ee-4ba4-9448-00ca2f82c7f2 --><!-- end item aa3e3c90-87cc-4a94-bd38-a29059be07f1 -->","subChapters":[]},{"id":"e678191a-ef23-5521-ad47-c9b3202690a7","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field e7c7b223-7c7f-4323-b056-8e2a4e3a3229 --><h3>New safety alerts</h3><!-- end field e7c7b223-7c7f-4323-b056-8e2a4e3a3229 -->","summary":null,"htmlStringContent":"<!-- begin item 6581c33e-ab7e-4b81-b7b5-4838879cd1e2 --><!-- begin field 3480fec7-d61d-409c-89c0-744711497e45 --><p>No new safety alerts since 1 June 2017.</p><!-- end field 3480fec7-d61d-409c-89c0-744711497e45 --><!-- end item 6581c33e-ab7e-4b81-b7b5-4838879cd1e2 -->","subChapters":[]},{"id":"ac87684e-d3cb-5e85-9099-62b875366c17","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field c1a5f8c4-4e51-4358-b5ed-b7b2d33f38f8 --><h3>Changes in product availability</h3><!-- end field c1a5f8c4-4e51-4358-b5ed-b7b2d33f38f8 -->","summary":null,"htmlStringContent":"<!-- begin item e52cc8f8-6ae2-46a7-aa01-044bcfac9c63 --><!-- begin field 6c602483-b6b3-4009-abe0-03d2fda17263 --><p>No changes in product availbality since 1 June 2017.</p><!-- end field 6c602483-b6b3-4009-abe0-03d2fda17263 --><!-- end item e52cc8f8-6ae2-46a7-aa01-044bcfac9c63 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}